A5044310130- Neurological and metabolic disorders
- Cerebrovascular and genetic disorders
- Cancer Treatment and Pharmacology
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Neurological Disorders and Treatments
- Intracerebral and Subarachnoid Hemorrhage Research
- Venous Thromboembolism Diagnosis and Management
- Parkinson's Disease and Spinal Disorders
- Pharmacological Effects and Toxicity Studies
- Neurological Disease Mechanisms and Treatments
- Acute Ischemic Stroke Management
Hospital Civil de Guadalajara
2023-2024
Objective: Focal status epilepticus requires timely diagnosis and treatment.Stroke is a common cause of epileptic seizures, but stroke-induced epilepsia partialis continua (SIEPC) rare type focal with unknown management prognosis.The aim the study was to present single-center case series patients admitted third-level referral hospital diagnosed SIEPC.Methods: We performed retrospective review assessing all in-hospital consultations from July 2021 2022 describing who presented SIEPC during...
<h3>Objective:</h3> Represent post-thrombolysis angioedema, a relatively common adverse effect seen after administration of alteplase for acute ischemic stroke. <h3>Background:</h3> r-TPA induced angioedema is clinical finding medication infusion The incidence this complication ranges from 1.3–8% (3, 4). Prognosis usually good; most patients have symptom resolution within 72 hours (5). <h3>Design/Methods:</h3> Literature review revealed how signs and symptoms differ in presentation severity....
<h3>Objective:</h3> To analyze those risk factors associated with metabolic syndrome in patients intracerebral hemorrhage. <h3>Background:</h3> Intracerebral hemorrhage (ICH) is a public health problem that generates high morbidity and mortality Mexico Latin America. Metabolic (MS) factor for cardiovascular disease ischemic stroke, but ICH only the association between arterial hypertension worse clinical outcomes recognized. <h3>Design/Methods:</h3> Data from three, longitudinal multicenter,...